DOUGLAS RICHARD - 07 Jun 2022 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Richard Douglas
Issuer symbol
ALDX
Transactions as of
07 Jun 2022
Net transactions value
$0
Form type
4
Filing time
09 Jun 2022, 17:06:09 UTC
Previous filing
15 Dec 2021
Next filing
14 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +53,812 $0.000000 53,812 07 Jun 2022 Common Stock 53,812 $3.60 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +13,917 $0.000000 13,917 07 Jun 2022 Common Stock 13,917 $3.60 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +1,624 $0.000000 1,624 07 Jun 2022 Common Stock 1,624 $3.60 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.